Closed · RFA-PS-24-063 · CFDA 93.941;93.943 · Discretionary
Minority HIV Research Initiative (MARI): Epidemiologic, Behavioral, and Implementation Science Research in Racial/Ethnic Minority Communities Disproportionately Affected by HIV and Build Research Capacity Among Historically Underrepresented Researchers
Federal grant opportunity posted by Centers for Disease Control and Prevention - ERA, cataloged on Grants.gov.
- $265K-$350K
- Award range
- Closed
- Status
- January 16, 2024
- Close date
- 5
- Expected awards
The verdict
Minority HIV Research Initiative (MARI): Epidemiologic, Behavioral, and Implementation Science Research in Racial/Ethnic Minority Communities Disproportionately Affected by HIV and Build Research Capacity Among Historically Underrepresented Researchers is a closed discretionary listing from Centers for Disease Control and Prevention - ERA that offered $265,000 -- $350,000 across 5 expected awards. Future funding cycles may be published under the same CFDA number.
- $265K-$350K
- award range
- Closed
- application status
- 5
- expected awards
- 93.941;93.943
- CFDA program
Opportunity snapshot. This Grants.gov announcement - Minority HIV Research Initiative (MARI): Epidemiologic, Behavioral, and Implementation Science Research in Racial/Ethnic Minority Communities Disproportionately Affected by HIV and Build Research Capacity Among Historically Underrepresented Researchers - is cataloged under number RFA-PS-24-063 and tied to CFDA assistance listing 93.941;93.943, posted by Centers for Disease Control and Prevention - ERA. Grants.gov currently shows the opportunity as closed, first posted on November 15, 2023. The funding category is Discretionary, delivered as a cooperative agreement.
Award economics. The award range on file is $265,000 -- $350,000. The agency has projected $7.0 million in total estimated funding for this announcement. It expects to issue 5 awards. If the agency funds the expected 5 awards from the $7.0 million estimated pool, the average award works out to roughly $1.4 million. Cost sharing is not required, so applicants do not need to commit matching funds to be competitive on this opportunity. Federal award ranges are often upper bounds; actual allocations reflect program appropriations, the strength of the applicant pool, and the evaluation committee's scoring.
Deadline and action path. This opportunity closed on January 16, 2024. Future funding cycles may be published under the same CFDA number, so monitoring the parent program page is the most reliable way to catch re-announcements. Every Grants.gov submission requires an active SAM.gov registration and a Unique Entity ID. Review the Eligibility section below carefully, federal eligibility categories (nonprofit, state or local government, tribal, individual, educational institution, small business) have distinct registration and reporting requirements. Pre-application outreach to the listed agency contact is permitted and often welcomed, it helps clarify scope and scoring priorities. Before acting on the deadline or award figures above, verify them directly on the official Grants.gov listing, amendments can change dates and amounts after this page was last refreshed.
Award Range
$265,000 -- $350,000
Close Date
January 16, 2024
Electronically submitted applications must be submitted no later than 11:59 pm ET on the listed application due date.
Posted
November 15, 2023
Est. Total Funding
$7,000,000
Expected Awards
5
Instrument
Cooperative Agreement
Description
The purpose of this Notice of Funding Opportunity (NOFO) is to support promising epidemiologic, behavioral, and implementation science research addressing the drivers of health inequities in racial and ethnic minority communities disproportionately affected by HIV while strengthening the capacity for conducting such research among underrepresented investigators working in these communities. The NOFO supports CDC’s goals to promote health and reduce disease and disability by funding research that has the potential to result in high public health impact.The NOFO is aligned with the federal initiative for Ending the HIV Epidemic in the United States (EHE) by 2030. The EHE plan encompasses the following four key strategies: (i) diagnose all individuals with HIV as early as possible; (ii) treat people with HIV rapidly and effectively to reach sustained viral suppression; (iii) prevent new HIV transmissions by using proven interventions, including PrEP and syringe services programs (SSPs); (iv) respond quickly to potential HIV outbreaks to get needed prevention and treatment services to people who need them.
Eligibility
Grants.gov lists this opportunity under eligibility category codes 00, 01, 02, 04, 05, 06, 07, 08, 11, 12, 13, 20, 22. These codes correspond to applicant types (state/local government, tribal organization, nonprofit, educational institution, individual, small business, etc.) defined in Grants.gov's own eligibility reference. See the current Grants.gov eligibility categories or check the official listing below for this opportunity's exact eligibility statement.
Official Listing on Grants.gov
View full details, application forms, and submission instructions.
Agency Contact
Jocelyn Mosley Patterson JPatterson@cdc.gov
Key Dates
Frequently Asked Questions
What is this grant opportunity?
Is this opportunity still open?
How much funding is available?
How do I apply?
More from Centers for Disease Control and Prevention - ERA
Occupational Safety and Health Training Project Grants (T03)
Occupational Safety and Health Education and Research Centers (T42)
RFA-PS-18-000
RFA-IP-18-000
RFA-CC-18-000
Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.
Read our methodology - how this data is sourced, computed, and verified.
Related
| Publisher | PlainGrants |
| Sources | the SAM.gov Assistance Listings and Grants.gov |